0001387131-19-008131.txt : 20191031
0001387131-19-008131.hdr.sgml : 20191031
20191031165055
ACCESSION NUMBER: 0001387131-19-008131
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191029
FILED AS OF DATE: 20191031
DATE AS OF CHANGE: 20191031
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Long David W
CENTRAL INDEX KEY: 0001642614
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37406
FILM NUMBER: 191184254
MAIL ADDRESS:
STREET 1: 309 WAVERLEY OAKS RD., SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corindus Vascular Robotics, Inc.
CENTRAL INDEX KEY: 0001528557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 300687898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 309 WAVERLEY OAKS ROAD
STREET 2: SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02452
BUSINESS PHONE: 508-653-3335
MAIL ADDRESS:
STREET 1: 309 WAVERLEY OAKS ROAD
STREET 2: SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02452
FORMER COMPANY:
FORMER CONFORMED NAME: Your Internet Defender, Inc
DATE OF NAME CHANGE: 20110824
4
1
long-form4_102919.xml
OWNERSHIP DOCUMENT
X0306
4
2019-10-29
1
0001528557
Corindus Vascular Robotics, Inc.
CVRS
0001642614
Long David W
309 WAVERLEY OAKS RD., SUITE 105
WALTHAM
MA
02452
0
1
0
0
CFO/Sr VP/Sec./Treasurer
Non-qualified stock option (right to buy)
0.5499
2019-10-29
4
D
0
590048
3.73
D
2021-09-04
Common Stock
590048
0
D
Non-qualified stock option (right to buy)
0.7507
2019-10-29
4
D
0
285773
3.5293
D
2024-06-04
Common Stock
285773
0
D
Non-qualified stock option (right to buy)
1.46
2019-10-29
4
D
0
100000
2.82
D
2026-06-22
Common Stock
100000
0
D
Non-qualified stock option (right to buy)
1.17
2019-10-29
4
D
0
100000
3.11
D
2027-04-06
Common Stock
100000
0
D
Non-qualified stock option (right to buy)
1.05
2019-10-29
4
D
0
110000
3.23
D
2028-02-01
Common Stock
110000
0
D
Non-qualified stock option (right to buy)
1.2
2019-10-29
4
D
0
110000
3.08
D
2029-01-31
Common Stock
110000
0
D
On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger").
This option provided for vesting over a period of four years, with the first 25% vesting on September 5, 2012 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter.
At the effective time of the Merger (the "Effective Time"), which occurred on October 29, 2019, each outstanding and unexercised option to purchase shares of the Issuer's common stock automatically converted into the right to receive a cash payment equal to the product of (i) the excess, if any, of $4.28 over the per share exercise price of such option, and (ii) the number of shares of the Issuer's common stock subject to such option as of the Effective Time, without interest and net of any applicable withholding taxes.
This option provided for vesting over a period of four years, with the first 25% vesting on June 5, 2015 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter.
This option provided for vesting over a period of four years, with the first 25% vesting on June 23, 2017 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter.
This option provided for vesting over a period of four years, with the first 25% vesting on April 7, 2018 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter.
This option provided for vesting over a period of four years, with the first 25% vesting on February 2, 2019 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter.
This option provided for vesting over a period of four years, with the first 25% vesting on February 1, 2020 and the remaining 75% vesting in 36 equal monthly installments at the end of every month thereafter.
/s/ David W. Long
2019-10-31